We welcome your Editorial plea ('Orphan giant' Nature 459, 1034; 2009) for stronger advocacy for tackling tuberculosis (TB), a shared global strategy and increased commitment to research and innovation. The emerging threat of drug-resistant TB in Europe, highlighted in a recent report from the European Academies Science Advisory Council (EASAC; http://www.easac.eu. (Correspondence)